Autologous hematopoietic stem cell transplantation following high-dose chemotherapy for nonrhabdomyosarcoma soft tissue sarcomas-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Autologous hematopoietic stem cell transplantation following high-dose chemotherapy for nonrhabdomyosarcoma soft tissue sarcomas

Published:2017-04-13 Issue: Volume: Page:
ISSN:1465-1858
Container-title:Cochrane Database of Systematic Reviews
language:en
Short-container-title:

Author:

Peinemann Frank¹,Enk Heike²,Smith Lesley A³

Affiliation:

1. Children's Hospital, University of Cologne; Pediatric Oncology and Hematology; Kerpener Str. 62 Cologne Germany 50937

2. c/o Cochrane Childhood Cancer; Amsterdam Netherlands

3. Oxford Brookes University; Department of Psychology, Social Work and Public Health; Jack Straws Lane Marston Oxford UK OX3 0FL

Publisher

Wiley

Subject

Pharmacology (medical)

Reference141 articles.

1. Consolidation with high-dose chemotherapy for responding patients to standard chemotherapy in advanced, metastatic soft tissue sarcoma (STS): a randomized trial from FNCLCC-French Sarcoma Group;Binh;Journal of Clinical Oncology,2009

2. High-dose chemotherapy consolidation for chemosensitive advanced soft tissue sarcoma patients: an open-label, randomized controlled trial;Bui-Nguyen;Annals of Oncology,2012

3. Retrospective inter- and intra-patient evaluation of trabectedin after best supportive care for patients with advanced translocation-related sarcoma after failure of standard chemotherapy;Araki;European Journal of Cancer,2016

4. High-dose chemotherapy (HDCT) with auto-SCT in children with atypical teratoid/rhabdoid tumors (AT/RT): a report from the European Rhabdoid Registry (EU-RHAB);Benesch;Bone Marrow Transplantation,2014

5. A parallel-arm phase I trial of the humanised anti-IGF-1R antibody dalotuzumab in combination with the AKT inhibitor MK-2206, the mTOR inhibitor ridaforolimus, or the NOTCH inhibitor MK-0752, in patients with advanced solid tumours;Brana;British Journal of Cancer,2014

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Whole-exome sequencing reveals genetic variants in low-risk and high-risk neuroblastoma;Gene;2023-04

2. Current status of producing autologous hematopoietic stem cells;Current Research in Translational Medicine;2023-01

3. Frühe Nutzenbewertung bei Arzneimitteln in der Hämatologie und Onkologie;InFo Hämatologie + Onkologie;2022-09

4. Autologous Stem-Cell Transplantation for High-Risk Neuroblastoma: Historical and Critical Review;Cancers;2022-05-24

5. Studying review articles in scientometrics and beyond: a research agenda;Scientometrics;2020-04-04

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3